Health Condition 1: C00-D49- Neoplasms
Conditions
Interventions
Intervention1: Oral Methadone: Patients in the methadone group will be supplied with tablets containing 5 mg of methadone. The dose consisted of 1/2 to 4 methadone tablets taken twice daily, every 12
Sponsors
Dr Varshali Keniya
Eligibility
Inclusion criteria
Inclusion criteria: All ages between 18 and 70 years Cancer patients Numerical Rating Score (NRS) for pain more than or equal to 5 Edmonton Classification System for Cancer Pain (ECS CP) Showing Ne (NEUROPATHIC and NOCIPECTIVE) Willing for informed consent
Exclusion criteria
Exclusion criteria: Patient’s refusal to participate in the study Patient not mentally competent to report From far places who cannot be followed up Patient with cardiac issues, abnormal baseline ECG and documented arrhythmias
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare effectiveness of oral Methadone versus oral Morphine in cancer patient using an 11- point NRS and ESC -CP score in reducing pain in cancer patientTimepoint: 0,7th,14th,21th,28th,35th,42th days | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare- 1. Cost effectiveness of Methadone vs Morphine. 2. Side effects of Methadone vs Morphine. 3. Opioid escalation index.Timepoint: 0,7,14,21,28,35,42 day | — |
Countries
India
Contacts
Public ContactDr Samreen Shaikh
Bharati Vidyapeeth(Deemed to be University) Medical College, Pune
Outcome results
None listed